SARS-CoV-2 re-infection: development of an epidemiological definition from India.
COVID-19
re-infection
viable virus
viral shedding
Journal
Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737
Informations de publication
Date de publication:
26 03 2021
26 03 2021
Historique:
pubmed:
27
3
2021
medline:
15
4
2021
entrez:
26
3
2021
Statut:
epublish
Résumé
The current investigation was conducted with the objective to develop an epidemiological case definition of possible severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) re-infection and assess its magnitude in India. The epidemiological case definition for SARS-CoV-2 re-infection was developed from literature review of data on viral kinetics. For achieving second objective, the individuals who satisfied the developed case definition for SARS-CoV-2 re-infection were contacted telephonically. Taking available evidence into consideration, re-infection with SARS-CoV-2 in our study was defined as any individual who tested positive for SARS-CoV-2 on two separate occasions by either molecular tests or rapid antigen test at an interval of at least 102 days with one negative molecular test in between. In this archive based, telephonic survey, 58 out of 1300 individuals (4.5%) fulfilled the above-mentioned definition; 38 individuals could be contacted with healthcare workers (HCWs) accounting for 31.6% of the cases. A large proportion of participants was asymptomatic and had higher Ct value during the first episode. While SARS-CoV-2 re-infection is still a rare phenomenon, there is a need for epidemiological definition of re-infection for establishing surveillance systems and this study contributes to such a goal.Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) re-infection is an emerging concern and there is a need to define it. Therefore, working epidemiological case definition for re-infection was developed and its magnitude was explored via archive-based, telephonic survey. Re-infection with SARS-CoV-2 was defined as two positive tests at an interval of at least 102 days with one interim negative test. Thirty-eight of the 58 eligible patients could be contacted with 12 (31.6%) being HCWs. Majority of the participants were asymptomatic and had higher Ct value during their first episode. To conclude, a working epidemiological case definition of SARS-CoV-2 re-infection is important to strengthen surveillance. The present investigation contributes to this goal and records reinfection in 4.5% of SARS-CoV-2 infected individuals in India.
Identifiants
pubmed: 33766185
doi: 10.1017/S0950268821000662
pii: S0950268821000662
pmc: PMC8027559
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e82Références
J Clin Virol. 2020 Jun;127:104346
pubmed: 32361324
Lancet Infect Dis. 2021 Jan;21(1):52-58
pubmed: 33058797
Clin Infect Dis. 2020 Nov 19;71(16):2240-2242
pubmed: 32302000
J Clin Microbiol. 2021 Jan 21;59(2):
pubmed: 33239378
Innovation (Camb). 2020 Nov 25;1(3):100061
pubmed: 33169119
Obstet Gynecol. 2020 Oct;136(4):838-841
pubmed: 32701763
Lancet Microbe. 2021 Jan;2(1):e13-e22
pubmed: 33521734
Clin Infect Dis. 2020 Jul 28;71(15):799-806
pubmed: 32271376
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
Emerg Infect Dis. 2004 Oct;10(10):1841-3
pubmed: 15504274
J Infect. 2021 Apr;82(4):84-123
pubmed: 33207255
Clin Infect Dis. 2021 Nov 2;73(9):e2946-e2951
pubmed: 32840608
J Med Virol. 2020 Nov;92(11):2286-2287
pubmed: 32347980
Emerg Microbes Infect. 2020 Dec;9(1):2571-2577
pubmed: 33196399
Clin Infect Dis. 2021 Nov 2;73(9):e2823-e2825
pubmed: 32964927
Clin Infect Dis. 2021 Jul 15;73(2):354-356
pubmed: 32887979
Sci Total Environ. 2020 Aug 1;728:138812
pubmed: 32335406